Micafungin

Micafungin, Mycamine

Echinocandin Antifungal

NADAC/unit N/A

No Shortage Tier 1: 38.3% PA Req: 2.4% 10 Manufacturers 20 ANDAs

Covered Lives

Market Intelligence

2024-07-17 Class III Recall: Zydus Pharmaceuticals (USA) Inc

Generic Manufacturers

BAXTER HEALTHCARE CORPBIOCON PHARMA LTDFRESENIUS KABI USA LLCHIKMA PHARMACEUTICALS INTERNATIONAL LTDHISUN PHARMACEUTICAL (HANGZHOU) CO LTDJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDMEITHEAL PHARMACEUTICALS INCPH HEALTH LTDQILU PHARMACEUTICAL HAINAN CO LTDXELLIA PHARMACEUTICALS APSYICHANG HUMANWELL PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Micafungin drfinder.aiFind doctors who prescribe Micafungin rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Micafungin

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.